Antibiotic Resistance and Toxin Production of Clostridium difficile Isolates from the Hospitalized Patients in a Large Hospital in Florida
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antibiotic Resistance and Toxin Production of Clostridium difficile Isolates from the Hospitalized Patients in a Large Hospital in Florida
Authors
Keywords
-
Journal
Frontiers in Microbiology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-12-22
DOI
10.3389/fmicb.2017.02584
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular typing and antimicrobial susceptibility testing to six antimicrobials of Clostridium difficile isolates from three Czech hospitals in Eastern Bohemia in 2011–2012
- (2017) V. Beran et al. FOLIA MICROBIOLOGICA
- Clostridium difficile infection: Evolution, phylogeny and molecular epidemiology
- (2017) Briony Elliott et al. INFECTION GENETICS AND EVOLUTION
- Update on Antimicrobial Resistance in Clostridium difficile: Resistance Mechanisms and Antimicrobial Susceptibility Testing
- (2017) Zhong Peng et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Clostridium difficile disease: Diagnosis, pathogenesis, and treatment update
- (2017) Lena M. Napolitano et al. SURGERY
- Subtyping and antimicrobial susceptibility of Clostridium difficile PCR ribotype 078/126 isolates of human and animal origin
- (2017) Sergio Álvarez-Pérez et al. VETERINARY MICROBIOLOGY
- Comparative genomic analysis of toxin-negative strains of Clostridium difficile from humans and animals with symptoms of gastrointestinal disease
- (2016) Piklu Roy Chowdhury et al. BMC MICROBIOLOGY
- CdtR Regulates TcdA and TcdB Production in Clostridium difficile
- (2016) Shelley A. Lyon et al. PLoS Pathogens
- Molecular Epidemiology and Antimicrobial Susceptibility of Clostridium difficile Isolates from a University Teaching Hospital in China
- (2016) Jing-Wei Cheng et al. Frontiers in Microbiology
- The binary toxin CDT enhances Clostridium difficile virulence by suppressing protective colonic eosinophilia
- (2016) Carrie A. Cowardin et al. Nature Microbiology
- U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin
- (2015) D. R. Snydman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes
- (2015) J. Freeman et al. CLINICAL MICROBIOLOGY AND INFECTION
- A national survey of the molecular epidemiology of Clostridium difficile in Israel: the dissemination of the ribotype 027 strain with reduced susceptibility to vancomycin and metronidazole
- (2015) Amos Adler et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Clostridium difficile Infection
- (2015) Daniel A. Leffler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Emergence of a Ribotype 244 Strain of Clostridium difficile Associated With Severe Disease and Related to the Epidemic Ribotype 027 Strain
- (2014) S. K. Lim et al. CLINICAL INFECTIOUS DISEASES
- Evolutionary History of the Clostridium difficile Pathogenicity Locus
- (2013) Kate E. Dingle et al. Genome Biology and Evolution
- Antimicrobial Susceptibility of Clostridium Difficile Clinical Isolates in Iran
- (2013) Mehdi Goudarzi et al. Iranian Red Crescent Medical Journal
- Fidaxomicin: The Newest Addition to the Armamentarium Against Clostridium difficile Infections
- (2012) Jason W. Lancaster et al. CLINICAL THERAPEUTICS
- Rifaximin disc diffusion test for in vitro susceptibility testing of Clostridium difficile
- (2011) S. Huhulescu et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
- (2010) Stuart H. Cohen et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Toxin B is essential for virulence of Clostridium difficile
- (2009) Dena Lyras et al. NATURE
- Rifampin and Rifaximin Resistance in Clinical Isolates of Clostridium difficile
- (2008) J. R. O'Connor et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection
- (2008) S. Persson et al. CLINICAL MICROBIOLOGY AND INFECTION
- Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in Europe
- (2008) P. Spigaglia et al. JOURNAL OF MEDICAL MICROBIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started